Lantern Pharma Enters into Strategic Collaboration with Deep Lens -- Partnership Expected to Accelerate Enrollment in Upcoming Phase 2 Clinical Trial for Never-Smokers with Non-Small Cell Lung Cancer
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Central Care Cancer Center and Deep Lens Partner to Integrate AI-Matching Solution, VIPER™, Into Network, Expanding Clinical Research Program
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
Press release content from Business Wire. The AP news staff was not involved in its creation.
Altru Health System Strengthens Clinical Trial Offering by Adopting Deep Lens’ Novel AI-Matching Solution, VIPER™
April 30, 2021 GMT
COLUMBUS, Ohio & GRAND FORKS, N.D. (BUSINESS WIRE) Apr 30, 2021
Deep Lens and Altru Health System today announced a strategic collaboration that will deploy artificial-intelligence (AI)-based clinical trial matching solution, VIPER, into the Altru Health System network. VIPER uses proprietary cloud-based technology to facilitate, triage and accelerate the enrollment of patients in the clinical trial recruitment process. VIPER is designed to improve efficiencies through automated screening and data management, which will present Altru with increased opportunities to participate in new precision medicine trials.